000 01193 a2200349 4500
005 20250514054613.0
264 0 _c20030303
008 200303s 0 0 eng d
022 _a1464-4096
024 7 _a10.1046/j.1464-410x.2003.03034.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDjavan, B
245 0 0 _aHeat versus drugs in the treatment of benign prostatic hyperplasia.
_h[electronic resource]
260 _bBJU international
_cJan 2003
300 _a131-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _a5-alpha Reductase Inhibitors
650 0 4 _aAdrenergic alpha-Antagonists
_xtherapeutic use
650 0 4 _aCatheterization
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aHyperthermia, Induced
_xmethods
650 0 4 _aMale
650 0 4 _aMicrowaves
_xtherapeutic use
650 0 4 _aPatient Selection
650 0 4 _aProstatic Hyperplasia
_xtherapy
650 0 4 _aTreatment Outcome
700 1 _aSeitz, C
700 1 _aMarberger, M
773 0 _tBJU international
_gvol. 91
_gno. 2
_gp. 131-7
856 4 0 _uhttps://doi.org/10.1046/j.1464-410x.2003.03034.x
_zAvailable from publisher's website
999 _c12321835
_d12321835